New Treatment Options Available September 9, 2020 Every man with prostate cancer deserves to know his germline BRCA 1/2 status and recent changes now make that possible and easier than ever. Medicare has expan... Continue Reading
Medicare Expands Coverage for BRACAnalysis CDx in Prostate Cancer September 1, 2020 Myriad Genetics, a leader in molecular diagnostics and precision medicine, announced that Medicare has expanded coverage for BRACAnalysis CDx® for men with pr... Continue Reading
A Message from Myriad Regarding COVID-19 March 19, 2020 A Message from Myriad Regarding COVID-19 In light of the public health preparedness efforts currently underway, Myriad’s top priorities are protecting the... Continue Reading
Once You Establish These Advanced Prostate Cancer Clinics, It's Easy to… February 15, 2020 Dr. Benjamin Lowntritt, Director of the Prostate Cancer Care Program at Chesapeake Urology, shares his success in setting up advanced prostate cancer clinics... Continue Reading
Having a Negative MRI Does Not Mean That You Don't Have a Significant Cancer. February 15, 2020 Dr. David Morris discusses the evolution of MRI in prostate cancer and reviews scenarios where MRI may be best suited. The impact MRI has on biopsy effect... Continue Reading
How Do You Get Experienced Urologists to Engage in the New Norm For Prostate Cancer? February 15, 2020 Listen to how Dr. Jason Hafron from the Michigan Institute of Urology, found his passion for Urologic care at a young age and how he has since become an infl... Continue Reading
When You Bring in a Partner, It’s the Unknown February 15, 2020 Is your practice considering an acquisition? Listen along as Dr. Mike Gambla from Central Ohio Urology Group shares his experience with private equity acquis... Continue Reading
If We Focus on Taking Care of The Patient, Everything Else Will Take Care of Itself February 15, 2020 E. Scot Davis, CEO of Arkansas Urology talks through his experience creating men’s health clinics and advanced treatment pathways to improve the competitiv... Continue Reading
Now We Can Look at Patients and Help Determine If They Need Treatment at All February 15, 2020 Listen to Dr. Jonathan Henderson, CEO of Regional Urology Shreveport Louisiana as he discusses his experience with being an early adopter of hereditary cance... Continue Reading
Genetics Is Impacting Every Aspect of Healthcare Now February 15, 2020 Sarah Nielsen, a genetic counselor from the University of Chicago, discusses the importance of educating physicians about how genetics and family history imp... Continue Reading
Gleason Grading Is Good to an Extent… February 15, 2020 Dr. Todd Cohen, VP of Medical Affairs at Myriad Genetics and Dr. Mark Edney, Medical Director at Peninsula Institute for Laparoscopic and Robotic Surgery dis... Continue Reading
I Could Talk About the Clinical Stuff, but I Needed to Know the Business Behind It February 11, 2020 Dr. Angelo Baccala, Division Chief of Urology at Lehigh Valley Hospital Network discusses the operational roadblocks he encountered in supporting his busines... Continue Reading
Applying Prolaris Data to an Evidentiary Framework February 15, 2018 Learn more about how the Prolaris® prostate cancer (PCa) prognostic test aligns with the widely cited and accepted Simon et al. evidentiary framework of 2009,... Continue Reading
Medicare Now Provides Coverage for Prolaris Testing August 13, 2015 Prolaris® Providers: We are pleased to announce that Medicare now provides coverage of Prolaris testing for Medicare Beneficiaries at AUA low-risk (NCCN very ... Continue Reading
Become a Provider for Prolaris Prostate Cancer Testing March 23, 2015 Why Should You Integrate Prolaris® in Your Prostate Cancer Risk Assessment? Prostate cancer is the most common cancer diagnosis for men in the United States a... Continue Reading